Oct 26, 2022 09:16AM
Oct 26, 2022 09:15AM
Oct 13, 2022 09:15AM
Aug 10, 2022 04:05PM
Jun 30, 2022 09:15AM
Jun 30, 2022 09:15AM
Apr 12, 2022 07:01AM Cyclacel Pharma (CYCC) Reports Publication Confirming Fadraciclib Suppresses MCL1 and Synergizes With Venetoclax in Chronic Lymphocytic Leukemia
Apr 12, 2022 07:00AM
Jan 6, 2022 07:00AM
Nov 10, 2021 04:05PM
Nov 5, 2021 09:41AM
Jul 13, 2021 07:00AM
May 12, 2021 04:25PM
May 12, 2021 04:05PM Cyclacel Pharmaceuticals Reports First Quarter 2021 Financial Results
Mar 12, 2021 09:19AM
Mar 11, 2021 05:37PM
Oct 26, 2020 08:27AM
Oct 26, 2020 08:26AM
Oct 26, 2020 08:26AM
Sep 9, 2019 07:02AM
Sep 9, 2019 07:00AM Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Patients With Advanced Solid Tumors
Jul 22, 2019 07:05AM
Jul 22, 2019 07:00AM
Sep 12, 2018 07:00AM
Aug 9, 2018 04:05PM
Apr 17, 2018 09:00AM
Apr 17, 2018 09:00AM
Apr 16, 2018 07:03AM Cyclacel Pharma (CYCC) Reports Update of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Meeting
Apr 16, 2018 07:00AM
Apr 16, 2018 07:00AM
Mar 28, 2018 04:05PM
Mar 28, 2018 04:05PM
Mar 15, 2018 07:00AM
Mar 15, 2018 07:00AM
Aug 7, 2017 07:16AM Cyclacel Pharma (CYCC) Reports Selection of Recommended Phase 2 Dose for CYC065
Aug 7, 2017 07:00AM
Apr 4, 2017 09:29AM
Apr 2, 2017 01:00PM
Mar 7, 2017 07:11AM
Mar 7, 2017 07:00AM
Feb 23, 2017 06:59AM
Feb 23, 2017 06:57AM Cyclacel Announces Top-Line Results From Pivotal Phase 3 SEAMLESS Study in Elderly Patients With Acute Myeloid Leukemia
Feb 6, 2017 07:00AM
Dec 27, 2016 01:54PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All